-
Precision Killers: Why Big Pharma Is Betting Billions To Beat A $170B Patent Cliff
15 Jan 2026 07:13 GMT
(MENAFN- PR Newswire)
Issued on behalf of Oncolytics Biotech Inc.
VANCOUVER, BC, Jan. 14, 2026 /PRNewswire/ -- Equity-Insider News Commentary – The precision oncology market is hitting a massive growth spurt, projected to rocket from $110 billion …
-
Triple play: Johnson & Johnson expands manufacturing footprint in NC
13 Jan 2026 19:26 GMT
North Carolina Governor Josh Stein announced that pharmaceutical giant Johnson & Johnson (J&J) will expand its presence in the state with a multibillion-dollar investment in a drug product manufacturing facility in Wilson. J&J stated that the …
-
<![CDATA[Johnson & Johnson Announces Second $2 Billion Manufacturing Facility in North Carolina ]]>
12 Jan 2026 19:33 GMT
… to construct a $2 billion pharmaceutical manufacturing campus in the city … in 2025), targeting manufacturing, research & development, and technology infrastructure up to … edpnc.com/news/johnson-johnson-building-another-multibillion-dollar-facility …
-
Axol Bioscience Secures $2.8M for U.S. Expansion, Product Development
13 Jan 2026 23:06 GMT
UK-based Axol Bioscience has raised $2.8 million (£2.1 million) in funding to accelerate expansion of U.S. operations and development.
The investment was led by BroadOak Capital Partners, a U.S. life sciences specialist, and joined by founding investor The …
-
Pharmaceutical manufacturing addition coming
13 Jan 2026 16:57 GMT
(The Center Square) – Drug products for oncology and neurological diseases will be manufactured in a second facility Johnson & Johnson plans to open in eastern North Carolina.
Nearly $80 million in incentives brought the first plant to Wilson County in …
-
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
13 Jan 2026 13:37 GMT
Decoy Therapeutics will use the platform, with funding support from the Gates Foundation, to provide widespread access to peptide-conjugate antivirals from Decoy's IMP3ACT™ platform for low- and middle-income countries.
CAMBRIDGE, Mass. and HOUSTON, …
-
Stem Cell Therapy Market is expected to generate a revenue of USD 404.3 Million by 2031, Globally, at 10.97% CAGR: Verified Market Research®
12 Jan 2026 15:39 GMT
Lewes, Delawa, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The Global Stem Cell Therapy Market Size is projected to grow at a CAGR of 10.97% from 2024 to 2031, according to a new report published by Verified Market Research®. The report reveals that the market was …
-
The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff
12 Jan 2026 15:14 GMT
VANCOUVER, British Columbia, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary – The biotechnology sector is entering a high-stakes survival sprint as major pharmaceutical giants confront a looming $170 billion patent cliff[1]. This …
-
Global Immunotherapy Drug Market Projected to Reach $467.4 Billion by 2030
15 Jan 2026 18:44 GMT
Boston, Jan. 15, 2026 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, “Immunotherapy Drugs: Global Markets” is expected to grow from $260.7 billion in 2025 to reach $467.4 billion by the end of 2030, at a compound annual growth rate ( …
-
ORIC® Pharmaceuticals Provides Operational Highlights for 2025 and Anticipated Upcoming Milestones
12 Jan 2026 13:30 GMT
Announced rinzimetostat (ORIC-944) Phase 1b data that continue to demonstrate potential best-in-class efficacy and safety in mCRPC; selected provisional RP2Ds and initiated dose optimization in combination with AR inhibitors Presented potential best-in- …
About
© 1995-2026